Dr Reddys Laboratories

NSE Announcements on Dr Reddys Labs

Posted by : MMB Messenger
Price when posted : [Dr Reddys Labs - BSE:Rs. 599.15 NSE:Rs. 600.50 when posted]

View full thread (1 messages)

Tracked by: 0 Boarder

Dr. ReddyS Laboratories Ltd. has informed the Exchange regarding a press release dated September 04, 2008, titled "Dr Reddys announces partnership with Cosmederm Technologies for Indian distribution of proprietary skin care products". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...

BSE Announcements on Dr Reddys Labs

Posted by : MMB Messenger
Price when posted : [Dr Reddys Labs - BSE:Rs. 598.95 NSE:Rs. 599.50 when posted]

View full thread (1 messages)

Tracked by: 0 Boarder

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated September 04, 2008 titled "Dr Reddys announces partnership with Cosmederm Technologies for Indian distribution of proprietary skin care products"...

BSE Announcements on Dr Reddys Labs

Posted by : MMB Messenger
Price when posted : [Dr Reddys Labs - BSE:Rs. 589.90 NSE:Rs. 589.70 when posted]

View full thread (1 messages)

Tracked by: 0 Boarder

Dr Reddys Laboratories Ltd has informed BSE that pursuant to Dr. Reddys Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 65,575 equity shares of Rs 5 each of the Company on August 27, 2008, to Directors / Employees who have exercised their Stock Options....

NSE Announcements on Dr Reddys Labs

Posted by : MMB Messenger
Price when posted : [Dr Reddys Labs - BSE:Rs. 589.90 NSE:Rs. 589.70 when posted]

View full thread (1 messages)

Tracked by: 0 Boarder

Dr. ReddyS Laboratories Ltd. has informed the Exchange that "Pursuant to Dr. Reddys Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 65,575 equity shares of Rs.5 each of the Company on August 27, 2008, to Directors / Employees who have exercised their Stock Options"....

www.multibaggerstockadvisor.blogspot.com

Posted by : Guest
Price when posted : BSE: Rs 590.00 ( -0.38 % ), NSE: Rs. 587.90 ( -0.83 % )

View full thread (1 messages)

Tracked by: 0 Boarder

in this volatile market there is essential need of a solid support or else its hard to take home profits...

it will be +ve up to 5-10% from this leve

Posted by : Harshad k shah
Price when posted : BSE: Rs 601.15 ( -0.12 % ), NSE: Rs. 602.65 ( -0.19 % )

View full thread (1 messages)

Tracked by: 0 Boarder

....DRL to form new derma co in US....

India Bureau Chief, PharmAsiaNews.com informed CNBC-TV18 that Dr Reddy’s Labs will form a new dermatology company in the US and is to be named Promius Pharma. Promius handles branded speciality dermatology products. He added that Promius will have its own marketing, product devlopment and licensing arrangment. The US prescription skincare and cosmoceutical market is seen at USD 10 billion. Meanwhile, Dr Reddy’s has refused to divulge details of the US derma company, he said.
...

NSE Announcements on Dr Reddys Labs

Posted by : MMB Messenger
Price when posted : [Dr Reddys Labs - BSE:Rs. 612.00 NSE:Rs. 613.00 when posted]

View full thread (1 messages)

Tracked by: 0 Boarder

Dr. ReddyS Laboratories Ltd. had informed the Exchange regarding outcome of the Annual General Meeting of the Company held on July 22, 2008. The Company has now informed the Exchange with reference to Item 8 of the outcome of the Annual General Meeting of the Company that, the proposed issue of 84,06,782 share warrants resulting into equity shares of Rs.5/- each at a later date of preferential basis in terms of Section 81 (1A) of the Companies Act, 1856 to Dr. Reddys Holdings Private Limited, as approved at the Annual General Meeting of the Company held on July 22, 2008 stands cancelled / withdrawn as the issue / allotment has not taken place in terms of Chapter XIII-Clause 13.1.2.3(a) and Clause 13.4.1 of SEBI (Disclosure& Investor Protection) Guidelines, 2000. Pursuant to this, the Company has withdraw its application made to the stock exchanges earlier, for in-principle approval sought in respect of the above shares....